Ethical Issues Arising from the Use of AI in Drug Discovery

Published: Feb 29, 2024
Artificial Intelligence Drug Discovery Algorithm Bias Data Security AI Ethics
Georgia Livieri
Charikleia Anastasopoulou
Konstantina Briola
Panagiota Nikolopoulou
Iris Panagiota Efthymiou

Lately, the pharmaceutical industry has been implementing artificial intelligence (AI) in research in multiple ways for the purpose of drug discovery. AI has great benefits to offer by performing tasks that a human may not be capable of. However, it also raises many ethical issues that need to be resolved. After describing the general picture, this paper explores the benefits and disadvantages of AI and attempts to find answers to the challenges it poses in order to make sure that its use will be ethical, fair, unbiased and beneficial to people. The challenges addressed below focus on ensuring patients’ safety from biased AI algorithms and violation of their data privacy, the need to train and inform staff properly, as well as the necessity of achieving an optimal level of trust towards AI. In the end, some policy recommendations are being presented, aiming to contribute to the centralized approach and to the balanced sense among the uses of AI. The key to success is always taking into account human agency in order to make AI’s use transparent and robust, while minimizing its risks.

Article Details
  • Section
  • Commentaries
Download data is not yet available.
Asan, O., Bayrak, A. E. & Choudhury, A. (2020). Artificial Intelligence and Human Trust in Healthcare: Focus on Clinicians. Journal of Medical Internet Research, 22(6), e15154.
Aydogdu, S. (2012). The effect of training in the improvement of employee efficiency in pharmaceutical industry and an application. Asia-Pacific Management and Business Application, 1(2), 129-139.
Bender, A., & Cortés-Ciriano, I. (2021). Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet. Drug Discovery Today, 26(2), 511-524.
Efthymiou, I. P., Vozikis, A., Sidiropoulos, S. (2019). Application of Sociocybernetic model in the field of Health Management. International Journal of Scientific and Engineering Research, 10(5), 451-560.
Tom, E., Keane, P. A., Blazes, M., Pasquale, L. R., Chiang, M. F., Lee, A. Y., Lee, C. S., and AAO Artificial Intelligence Task Force. (2020). Protecting Data Privacy in the Age of AI-Enabled Ophthalmology. Translational Vision Science and Technology, 9(2), 1-7.
Hoffman, R. R., Johnson, M., Bradshaw, J.M. & Underbrink, A. (2013). Trust in automation. IEEE Intelligent System, 28(1), 84-88. 10.1109/MIS.2013.24
Indrajit, H. (2020). Artificial intelligence: opportunities and implications for the health workforce. International Health, 12(4), 241–245. 10.1093/inthealth/ihaa007
Jobin, A., Ienca, M., & Vayena, E. (2019). The global landscape of AI ethics guidelines. Nature Machine Intelligence, 1, 389-399.
Joyce, K., Smith-Doerr, L., Alegria, S., Bell, S., Cruz, T., Hoffman, S.G., Noble, S.U., Shestakofsky, B. (2021). Toward a Sociology of Artificial Intelligence: A Call for Research on Inequalities and Structural Change. Socius: Sociological Research for a Dynamic World, 7.
Kim, H., Kim, E., Lee, I., Bae, B., Park, M., & Nam, H. (2020). Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches. Biotechnology and Bioprocess Engineering, 25(6), 895–930. 10.1007/s12257-020-0049-y
Izdebski, Κ. (2020). Preventing the potential discriminatory effects of the use of artificial intelligence in local services. Policy Brief, Council of Europe and Epaństwo Foundation. Retrieved from
Lamberti, M. J., Wilkinson, M., Donzanti, B. A., Wohlhieter, E. G., Parikh, S., Wilkins, R. G., & Getz, K. (2019). A study on the application and use of artificial intelligence. Clinical therapeutics, 41(8), 1414-1426.
Lee, J.D. & See, K.A. (2004). Trust in automation: Designing for appropriate reliance. Human Factors, 46(1), 50-80. 10.1518/hfes.46.1.50_30392.
Mak, K.-K., & Pichika, M. R. (2019). Artificial intelligence in drug development: present status and future prospects. Drug discovery today, 24(3), 773-780.
Mehrabi, N., Morstatter, F., Saxena, N., Lerman, K., & Galstyan, A. (2019). A Survey on Bias and Fairness in Machine Learning. ACM Computing Surveys (CSUR), 54, 1-35.
Mohanty, P. (2019). Do You Fear Artificial Intelligence Will Take Your Job? Forbes. Accessed 20/08/2021. Retrieved from
Niranjana, G. & Chatterjee, D. (2021). Security and Privacy Issues in Biomedical AI Systems and Potential Solutions. In Handbook of Artificial Intelligence in Biomedical Engineering. Apple Academic Press, New York.
Panch, T., Szolovits, P., & Atun, R. (2018). Artificial intelligence, machine learning and health systems. Journal of Global Health, 8(2), 020303. 10.7189/jogh.08.020303
Panch, T., Mattie, H. & Celi, L.A. (2019). The “inconvenient truth” about AI in healthcare. NPJ Digital Medicine, 2, 77.
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2020). Artificial intelligence in drug discovery and development. Drug Discovery Today, 26(1), 80-93.
Sánchez-Monedero, J., Dencik, L., & Edwards, L. (2020). What does it mean to 'solve' the problem of discrimination in hiring? social, technical and legal perspectives from the UK on automated hiring systems. Proceedings of the 2020 Conference on Fairness, Accountability, and Transparency. Retrieved from
Timan, T. & Mann, Z. Á. (2019). Data protection in the era of artificial intelligence. Trends, existing solutions and recommendations for privacy-preserving technologies. BDVA. Retrieved from: